Including Wellness in the Pharma Model - How Drug Delivery will be a Key Enabler

In this industry keynote recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference, Justin Wright, PhD, Global Head of Innovation, Novartis, discusses how the transformation from traditional drugs to next-generation product systems, where sometimes the drug is only a component of the overall product offering, is creating a opportunity for non-traditional competitors and start-ups to access the market and potentially redefine the value model associated with drug pricing. To stay competitive, the pharmaceutical industry’s current business model needs to evolve rapidly from a reactive to a prevention model. At the core of this type of evolved model will be a dynamic patient interface with extraordinary patient engagement. And the delivery system will undoubtedly be a key enabler in the process. Dr Wright reviews the current and future state with his perspective and cases studies to help shed light on the key areas where focus is needed focus and corresponding opportunities lie. Join us for the 9th annual PODD conference business development event on October 7-8, 2019 at the Renaissance Boston Waterfront Hotel in Boston. PODD covers the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships. To learn more about the event, please visit PODD 2019.